Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Transfus Apher Sci ; 47(1): 85-9, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22609019

RESUMO

Iron deficiency (ID) is a global health problem. We aimed to determine the prevalence of ID at the first year of life in infants who were hospitalized in our neonatal intensive care unit (NICU) and investigate the effects of various factors on iron status. One year follow-up data of 219 infants who were discharged from NICU was retrospectively evaluated. ID anemia and ID without anemia were detected in fifteen infants (6.8%) and five (2.3%) infants, respectively. We concluded that, due to prophylactic iron treatment and close follow-up, hospitalization in neonatal period did not have any adverse effect on iron status at first year of life.


Assuntos
Anemia Ferropriva/epidemiologia , Hospitalização , Deficiências de Ferro , Anemia Ferropriva/sangue , Anemia Ferropriva/prevenção & controle , Feminino , Seguimentos , Humanos , Lactente , Masculino , Prevalência
2.
Turk J Pediatr ; 53(3): 337-41, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21980820

RESUMO

Congenital cystic adenomatoid malformation (CCAM) is a rare bronchopulmonary malformation characterized by loss of the normal pulmonary tissue. CCAM may be frequently associated with cardiac and renal anomalies. Rarely, CCAM may be seen with chromosome abnormalities. This is the first reported neonatal case of prenatally detected CCAM and postnatally diagnosed trisomy 13.


Assuntos
Anormalidades Múltiplas/genética , Cromossomos Humanos Par 13 , Malformação Adenomatoide Cística Congênita do Pulmão/diagnóstico por imagem , Trissomia , Ultrassonografia Pré-Natal , Anormalidades Múltiplas/patologia , Malformação Adenomatoide Cística Congênita do Pulmão/complicações , Feminino , Humanos , Recém-Nascido
3.
Eur J Pediatr Surg ; 20(5): 339-40, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20625976

RESUMO

INTRODUCTION: The aim of this study was to determine the normal position of the umbilicus so as to offer a guide to improve cosmetic results after the repair of congenital abdominal wall defects. MATERIALS AND METHODS: The position of the umbilical center was determined in 187 neonates with respect to the xiphoid process, the center of the umbilicus and the pubis. The distance between the xiphoid process and the center of the umbilicus (XU), between the pubis and the center of the umbilicus (PU) and from the xiphoid process to the pubis (XP) were measured while the babies lay in a supine position. The PU:XU ratio was calculated based on these measurements. RESULTS: Mean XP was 11.93±1.40 cm, mean XU was 7.41±1.08 cm and mean PU was 4.52±0.70 (mean±SD). The PU:XU ratio was calculated as 0.61±0.12 (ratio±SD). CONCLUSION: We suggest that the PU:XU ratio should be 0.61 offering an ideal localization in umbilical reconstruction.


Assuntos
Umbigo/anatomia & histologia , Antropometria , Feminino , Humanos , Recém-Nascido , Masculino , Osso Púbico/anatomia & histologia , Processo Xifoide/anatomia & histologia
4.
Eur J Pediatr Surg ; 18(1): 56-8, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18302073

RESUMO

Enterocutaneous fistula (EF) in newborns and prematures is a well-recognized complication after necrotizing enterocolitis and other abdominal surgical procedures. Conservative management consists of bowel rest, antibiotics, wound care, and the administration of drugs that either reduce gastrointestinal motility or secretions. Octreotide decreases gastrointestinal secretions, inhibits or blocks the effects of gastrointestinal hormones, diminishes gut motility and thus reduces the flow through the fistula. We used octreotide and were able to report successful spontaneous closure of a fistula in our 2 neonatal patients, one a premature neonate with necrotizing enterocolitis (NEC) and the other with meconium peritonitis.


Assuntos
Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Fármacos Gastrointestinais/uso terapêutico , Fístula Intestinal/tratamento farmacológico , Fístula Intestinal/etiologia , Octreotida/uso terapêutico , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA